Artivion SVP sells shares to cover taxes

Artivion, Inc. SVP Stanton Marshall S. reported two open-market sales of common stock that were executed solely to cover tax withholding on vesting equity awards.

Rhea-AI Filing Summary

Artivion, Inc. SVP Stanton Marshall S. reported two open-market sales of common stock that were executed solely to cover tax withholding on vesting equity awards. On February 23, 2026, he sold 2,423 shares at an average price of $37.588 per share. On February 24, 2026, he sold an additional 1,259 shares at an average price of $35.693 per share. The footnotes state these were "sell to cover" transactions to satisfy tax obligations and did not represent discretionary trading decisions. After the latest transaction, he directly owned 41,921 common shares.

Insider Trade Summary

Net Seller: 3,682 shares

Net Sell 2 txns

Insider Stanton Marshall S.

Role SVP, Clinical & MD Affair

Sold 3,682 shs ($136K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,259	$35.693	$45K
Sale	Common Stock	2,423	$37.588	$91K

Holdings After Transaction: Common Stock — 41,921 shares (Direct)

Footnotes (2)

1. F1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
2. F2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Artivion (AORT) report for Stanton Marshall S.?

Artivion reported that SVP Stanton Marshall S. sold 2,423 common shares on February 23, 2026, and 1,259 shares on February 24, 2026. Both transactions were executed as open-market sales tied to equity award vesting.

Why did Artivion SVP Stanton Marshall S. sell AORT shares?

The filing states the shares were sold to pay tax withholding obligations arising from vesting performance and restricted stock units. These "sell to cover" transactions were not discretionary trades, but automatic sales to fund required tax payments.

At what prices did the Artivion (AORT) insider share sales occur?

On February 23, 2026, 2,423 Artivion common shares were sold at an average price of $37.588. On February 24, 2026, 1,259 shares were sold at an average price of $35.693, according to the Form 4 disclosure.

How many Artivion (AORT) shares does Stanton Marshall S. hold after the sales?

Following the most recent transaction on February 24, 2026, Stanton Marshall S. directly owned 41,921 shares of Artivion common stock. This post-transaction balance reflects his holdings after completing the tax-related sell-to-cover trades.

Are the recent Artivion (AORT) insider sales considered discretionary trades?

The Form 4 footnotes explain these sales were made to satisfy tax withholding obligations from vesting performance and restricted stock units. They are described as "sell to cover" transactions and explicitly noted as not representing discretionary trading decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 05:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stanton Marshall S.

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Clinical & MD Affair

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		S		2,423(1)	D	$37.588	43,180	D
Common Stock	02/24/2026		S		1,259(2)	D	$35.693	41,921	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Remarks:

	/s/ Marshall Stanton	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.